Submitted by Anonymous (not verified) on 1 February 2024 - 9:53
Orphan designation: 6-(4-(1-amino-3-hydroxycyclobutyl)phenyl)-1-ethyl-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, L-tartrate salt Treatment of hereditary haemorrhagic telangiectasia, 20/03/2023 Positive
Source:
